Peru ’s clinical trials of China ’s Sinopharm coronavirus vaccine were temporarily suspended by the Peruvian National Institute of Health after a participant reported a decrease in muscle strength in his legs , German Malaga , the head of clinical trials at Sinopharm laboratories in Peru told CNN on Sunday . 
The 64 year old patient , with allegedly more than 20 years of badly controlled diabetes , is in stable condition , Malaga said . 
Malaga added that the reason for the symptoms cannot yet be determined and an investigation is ongoing . 
